Glenmark Pharmaceuticals Market Cap

Glenmark Pharmaceuticals has a market cap or net worth of 399.99 billion as of May 13, 2025. Its market cap has increased by 36.38% in one year.

Market Cap

399.99B

Enterprise Value

399.60B

Revenue

139.61B

Ranking

n/a

PE Ratio

n/a

Stock Price

1,417.40

Market Cap Chart

Since June 7, 2001, Glenmark Pharmaceuticals's market cap has increased from 1.15B to 399.99B, an increase of 34,702.95%. That is a compound annual growth rate of 27.69%.

Market Cap History

Date	Market Cap	% Change
May 12, 2025	389.92B	-14.13%
Dec 31, 2024	454.07B	88.44%
Dec 29, 2023	240.96B	101.33%
Dec 30, 2022	119.68B	-19.75%
Dec 31, 2021	149.14B	7.10%
Dec 31, 2020	139.25B	42.03%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Sun Pharmaceutical Industries	4,186.36B
Divi's Laboratories	1,599.58B
Cipla	1,195.31B
Mankind Pharma	993.57B
Apollo Hospitals Enterprise	966.52B
Zydus Lifesciences	884.13B
Aurobindo Pharma	676.29B
Alkem Laboratories	591.43B

Market Cap Rankings